JGP Wealth Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
AIM
EB
CPC
AIM
AAMU
AAIS
SIC
BCAM
JGP Wealth Management's DGX Position: Q2 2026 in Review
JGP Wealth Management reduced its Quest Diagnostics (DGX) stake by 0.86% in Q2 2026, selling an estimated $114K and leaving 66,982 shares worth $14.2M. The position accounts for 1.27% of the portfolio, ranked #19.
JGP Wealth Management first reported a position in DGX in Q1 2020 and has held it in 26 quarters since. The position peaked at $15.6M in Q4 2022. 322 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- JGP Wealth Management held 66,982 shares of Quest Diagnostics worth $14.2M as of Q2 2026.
- JGP Wealth Management sold 580 Quest Diagnostics shares in Q2 2026, an estimated $114K.
- Quest Diagnostics made up 1.27% of JGP Wealth Management's portfolio in Q2 2026, its #19 holding.
- JGP Wealth Management first reported a position in Quest Diagnostics in Q1 2020 and has held it in 26 quarters since.
- JGP Wealth Management's Quest Diagnostics position peaked at $15.6M in Q4 2022.
- 322 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on JGP Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.